Arvind Kumar Shukla is working on the Molecular mechanism of Cancer Stem Cells Biology. He is the main focus in the fabrication of functional tissue/organs development by 3D Bioprinting with a study on Stem cells & Cancer signaling pathways and also focuses on various cancer drugs delivery, which are used tested clinically for treatment of Chronic Myeloid Leukemia (CML), Acute myeloid leukemia (AML), Colorectal Cancer (CRC), Breast Cancer and other type of Solid Cancer. He is focus basic medical and scientific research on cancer biology two areas: 1) the mechanisms by which cancers invade and metastasize and 2) the mechanisms by which cancer cells evade immune responses. Cancer arises in a multi-step process in which normal cells acquire mutations through the activation of oncogenes and the loss of tumor suppressor mechanisms. He is interested in examining the signaling pathways in cancer cells in order to understand the molecular events leading to tumor growth, invasion, metastasis, immune suppression and multidrug resistance.